Safety and Efficacy of Intravenous Golimumab in Patients With Active Psoriatic Arthritis: Results Through Week Twenty‐Four of the GO‐VIBRANT Study

por Kavanaugh, Arthur, Husni, M. Elaine, Harrison, Diane D., Kim, Lilianne, Lo, Kim Hung, Leu, Jocelyn H., Hsia, Elizabeth C.
Publicado 2017

Maintenance of Clinical and Radiographic Benefit With Intravenous Golimumab Therapy in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy: Week‐112 Efficacy and...

por Bingham, Clifton O., Mendelsohn, Alan M., Kim, Lilianne, Xu, Zhenhua, Leu, Jocelyn, Han, Chenglong, Lo, Kim Hung, Westhovens, Rene, Weinblatt, Michael E.
Publicado 2015

Evaluation of Improvement in Skin and Nail Psoriasis in Bio‐naïve Patients With Active Psoriatic Arthritis Treated With Golimumab: Results Through Week 52 of the GO‐VIBRANT Study...

por Mease, Philip, Elaine Husni, M., Chakravarty, Soumya D., Kafka, Shelly, Parenti, Dennis, Kim, Lilianne, Hung Lo, Kim, Hsia, Elizabeth C., Kavanaugh, Arthur
Publicado 2020

Efficacy and Safety of Intravenous Golimumab Through One Year in Patients With Active Psoriatic Arthritis

por Husni, M. Elaine, Kavanaugh, Arthur, Murphy, Frederick, Rekalov, Dmytro, Harrison, Diane D., Kim, Lilianne, Lo, Kim Hung, Leu, Jocelyn H., Hsia, Elizabeth C.
Publicado 2020

Effect of Intravenous Golimumab on Fatigue and the Relationship with Clinical Response in Adults with Active Ankylosing Spondylitis in the Phase 3 GO-ALIVE Study

por Deodhar, Atul, Shiff, Natalie J., Gong, Cinty, Chan, Eric K. H., Hsia, Elizabeth C., Lo, Kim Hung, Akawung, Alianu, Kim, Lilianne, Xu, Stephen, Reveille, John D.
Publicado 2023

Radiographic benefit and maintenance of clinical benefit with intravenous golimumab therapy in patients with active rheumatoid arthritis despite methotrexate therapy: results up to...

por Weinblatt, Michael E, Westhovens, Rene, Mendelsohn, Alan M, Kim, Lilianne, Lo, Kim Hung, Sheng, Shihong, Noonan, Lenore, Lu, Jiandong, Xu, Zhenhua, Leu, Jocelyn, Baker, Daniel, Bingham, Clifton O
Publicado 2014

The effect of intravenous golimumab on health-related quality of life and work productivity in patients with active psoriatic arthritis: results of the Phase 3 GO-VIBRANT trial

por Ogdie, Alexis, Walsh, Jessica A., Chakravarty, Soumya D., Peterson, Steven, Lo, Kim Hung, Kim, Lilianne, Li, Nan, Hsia, Elizabeth C., Chan, Eric K. H., Kavanaugh, Arthur, Husni, M. Elaine
Publicado 2021

Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial

por Brunner, Hermine I, Ruperto, Nicolino, Tzaribachev, Nikolay, Horneff, Gerd, Chasnyk, Vyacheslav G, Panaviene, Violeta, Abud-Mendoza, Carlos, Reiff, Andreas, Alexeeva, Ekaterina, Rubio-Pérez, Nadina, Keltsev, Vladimir, Kingsbury, Daniel J, del Rocio Maldonado Velázquez, Maria, Nikishina, Irina, Silverman, Earl D, Joos, Rik, Smolewska, Elzbieta, Bandeira, Márcia, Minden, Kirsten, van Royen-Kerkhof, Annet, Emminger, Wolfgang, Foeldvari, Ivan, Lauwerys, Bernard R, Sztajnbok, Flavio, Gilmer, Keith E, Xu, Zhenhua, Leu, Jocelyn H, Kim, Lilianne, Lamberth, Sarah L, Loza, Matthew J, Lovell, Daniel J, Martini, Alberto
Publicado 2018